The DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.
Strategies in the design of antiviral drugs
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rational design of potent sialidase-based inhibitors of influenza virus replication
von Itzstein, M., Wu, W.-Y., Kok, G. B., Pegg, M. S., Dyason, J. C., Jin, B., Van Phan, T., Smythe, M. L., White, H. F., Oliver, S. W., et al. (1993) · Nature · doi:10.1038/363418a0 · Cited by 1,862
Inhibitors of Strand Transfer That Prevent Integration and Inhibit HIV-1 Replication in Cells
Hazuda, D. J., Felock, P., Witmer, M., Wolfe, A., Stillmock, K., Grobler, J. A., Espeseth, A., Gabryelski, L., Schleif, W., Blau, C., et al. (2000) · Science · doi:10.1126/science.287.5453.646 · Cited by 1,131
Kim, C. U., Lew, W., Williams, M. A., Liu, H., Zhang, L., Swaminathan, S., Bischofberger, N., Chen, M. S., Mendel, D. B., Tai, C. Y., et al. (1997) · Journal of the American Chemical Society · doi:10.1021/ja963036t · Cited by 1,100
Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate
Chen, Y., Maguire, T., Hileman, R. E., Fromm, J. R., Esko, J. D., Linhardt, R. J., & Marks, R. M. (1997) · Nature Medicine · doi:10.1038/nm0897-866 · Cited by 1,063
A Novel Role for 3-O-Sulfated Heparan Sulfate in Herpes Simplex Virus 1 Entry
Shukla, D., Liu, J., Blaiklock, P., Shworak, N. W., Bai, X., Esko, J. D., Cohen, G. H., Eisenberg, R. J., Rosenberg, R. D., & Spear, P. G. (1999) · Cell · doi:10.1016/s0092-8674(00)80058-6 · Cited by 1,054
Kilby, J. M., Hopkins, S., Venetta, T. M., DiMassimo, B., Cloud, G. A., Lee, J. Y., Alldredge, L., Hunter, E., Lambert, D., Bolognesi, D., et al. (1998) · Nature Medicine · doi:10.1038/3293 · Cited by 987
RNA virus error catastrophe: Direct molecular test by using ribavirin
Crotty, S., Cameron, C. E., & Andino, R. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.111085598 · Cited by 849
The broad-spectrum antiviral ribonucleoside ribavirin is an RNA virus mutagen
Crotty, S., Maag, D., Arnold, J. J., Zhong, W., Lau, J. Y. N., Hong, Z., Andino, R., & Cameron, C. E. (2000) · Nature Medicine · doi:10.1038/82191 · Cited by 820
Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial
Nicholson, K., Aoki, F., Osterhaus, A., Trottier, S., Carewicz, O., Mercier, C., Rode, A., Kinnersley, N., & Ward, P. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02288-1 · Cited by 785
A novel selective broad-spectrum anti-DNA virus agent
Clercq, E. D., Holý, A., Rosenberg, I., Sakuma, T., Balzarini, J., & Maudgal, P. C. (1986) · Nature · doi:10.1038/323464a0 · Cited by 764
Hayden, F. G., Osterhaus, A. D. M. E., Treanor, J. J., Fleming, D. M., Aoki, F. Y., Nicholson, K. G., Bohnen, A. M., Hirst, H. M., Keene, O., & Wightman, K. (1997) · New England Journal of Medicine · doi:10.1056/nejm199709253371302 · Cited by 762
A small-molecule, nonpeptide CCR5 antagonist with highly potent and selective anti-HIV-1 activity
Baba, M., Nishimura, O., Kanzaki, N., Okamoto, M., Sawada, H., Iizawa, Y., Shiraishi, M., Aramaki, Y., Okonogi, K., Ogawa, Y., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.10.5698 · Cited by 751
Inhibition of T-tropic HIV Strains by Selective Antagonization of the Chemokine Receptor CXCR4
Schols, D., Struyf, S., Damme, J. V., Esté, J. A., Henson, G., & Clercq, E. D. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.8.1383 · Cited by 554
Hayden, F. G., Treanor, J. J., Fritz, R. S., Lobo, M., Betts, R. F., Miller, M., Kinnersley, N., Mills, R. G., Ward, P., & Straus, S. E. (1999) · JAMA · doi:10.1001/jama.282.13.1240 · Cited by 550
A Mouse Model for Evaluation of Prophylaxis and Therapy of Ebola Hemorrhagic Fever
Bray, M., Davis, K., Geisbert, T., Schmaljohn, C., & Huggins, J. (1998) · The Journal of Infectious Diseases · doi:10.1086/515386 · Cited by 492
Flavopiridol Inhibits P-TEFb and Blocks HIV-1 Replication
Chao, S.-H., Fujinaga, K., Marion, J. E., Taube, R., Sausville, E. A., Senderowicz, A. M., Peterlin, B. M., & Price, D. H. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.c000446200 · Cited by 455
Eckert, D. M., Malashkevich, V. N., Hong, L. H., Carr, P. A., & Kim, P. S. (1999) · Cell · doi:10.1016/s0092-8674(00)80066-5 · Cited by 442
Dragic, T., Trkola, A., Thompson, D. A. D., Cormier, E. G., Kajumo, F. A., Maxwell, E., Lin, S. W., Ying, W., Smith, S. O., Sakmar, T. P., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.090576697 · Cited by 426
Sintchak, M. D., Fleming, M. A., Futer, O., Raybuck, S. A., Chambers, S. P., Caron, P. R., Murcko, M. A., & Wilson, K. P. (1996) · Cell · doi:10.1016/s0092-8674(00)81275-1 · Cited by 423
Protein Design of an HIV-1 Entry Inhibitor
Root, M. J., Kay, M. S., & Kim, P. S. (2001) · Science · doi:10.1126/science.1057453 · Cited by 391
De Clercq, E. (1998) · Antiviral Research · doi:10.1016/s0166-3542(98)00025-4 · Cited by 358
Self-citationLambert, D. M., Barney, S., Lambert, A. L., Guthrie, K., Medinas, R., Davis, D. E., Bucy, T., Erickson, J., Merutka, G., & Petteway, S. R. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.5.2186 · Cited by 336
Matthews, D. A., Dragovich, P. S., Webber, S. E., Fuhrman, S. A., Patick, A. K., Zalman, L. S., Hendrickson, T. F., Love, R. A., Prins, T. J., Marakovits, J. T., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.20.11000 · Cited by 318
Strizki, J. M., Xu, S., Wagner, N. E., Wojcik, L., Liu, J., Hou, Y., Endres, M., Palani, A., Shapiro, S., Clader, J. W., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.221375398 · Cited by 299
Antiviral drugs: current state of the art
De Clercq, E. (2001) · Journal of Clinical Virology · doi:10.1016/s1386-6532(01)00167-6 · Cited by 263
Self-citationMendel, D. B., Tai, C. Y., Escarpe, P. A., Li, W., Sidwell, R. W., Huffman, J. H., Sweet, C., Jakeman, K. J., Merson, J., Lacy, S. A., et al. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.3.640 · Cited by 255
An inhibitor of the Tat/TAR RNA interaction that effectively suppresses HIV-1 replication
Hamy, F., Felder, E. R., Heizmann, G., Lazdins, J., Aboul-ela, F., Varani, G., Karn, J., & Klimkait, T. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.8.3548 · Cited by 241
Protease Inhibitors as Antiviral Agents
Patick, A. K., & Potts, K. E. (1998) · Clinical Microbiology Reviews · doi:10.1128/cmr.11.4.614 · Cited by 221
In Vitro Antiviral Activity of AG7088, a Potent Inhibitor of Human Rhinovirus 3C Protease
Patick, A. K., Binford, S. L., Brothers, M. A., Jackson, R. L., Ford, C. E., Diem, M. D., Maldonado, F., Dragovich, P. S., Zhou, R., Prins, T. J., et al. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.10.2444 · Cited by 221
4-Aryl-2,4-dioxobutanoic Acid Inhibitors of HIV-1 Integrase and Viral Replication in Cells
Wai, J. S., Egbertson, M. S., Payne, L. S., Fisher, T. E., Embrey, M. W., Tran, L. O., Melamed, J. Y., Langford, H. M., Guare, Zhuang, L., et al. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm000176b · Cited by 188
The HIV-1 Reverse Transcription (RT) Process as Target for RT Inhibitors
Jonckheere, H., Ann�, J., & De Clercq, E. (2000) · Medicinal Research Reviews · doi:10.1002/(sici)1098-1128(200003)20:2<129::aid-med2>3.0.co;2-a · Cited by 181
Self-citationDragovich, P. S., Prins, T. J., Zhou, R., Webber, S. E., Marakovits, J. T., Fuhrman, S. A., Patick, A. K., Matthews, D. A., Lee, C. A., Ford, C. E., et al. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm9805384 · Cited by 180
Structural Mechanisms of HIV Drug Resistance
Erickson, J. W., & Burt, S. K. (1996) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.36.040196.002553 · Cited by 175
Cyclopentane Neuraminidase Inhibitors with Potent In Vitro Anti-Influenza Virus Activities
Smee, D. F., Huffman, J. H., Morrison, A. C., Barnard, D. L., & Sidwell, R. W. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.3.743-748.2001 · Cited by 170
Bray, M., Driscoll, J., & Huggins, J. W. (2000) · Antiviral Research · doi:10.1016/s0166-3542(00)00066-8 · Cited by 158
A Mouse Model for Evaluation of Prophylaxis and Therapy of Ebola Hemorrhagic Fever
Bray, M., Davis, K., Geisbert, T., Schmaljohn, C. S., & Huggins, J. W. (1999) · The Journal of Infectious Diseases · doi:10.1086/514292 · Cited by 153
Bantia, S., Parker, C. D., Ananth, S. L., Horn, L. L., Andries, K., Chand, P., Kotian, P. L., Dehghani, A., El-Kattan, Y. A., Lin, T., et al. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.4.1162-1167.2001 · Cited by 151
The Herpesvirus Proteases as Targets for Antiviral Chemotherapy
Waxman, L., & Darke, P. L. (2000) · Antiviral chemistry & chemotherapy · doi:10.1177/095632020001100101 · Cited by 122
Ren, J., Nichols, C. E., Bird, L. E., Fujiwara, T., Sugimoto, H., Stuart, D. I., & STAMMERS, D. K. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.19.14316 · Cited by 121
Hatse, S., Princen, K., Gerlach, L., Bridger, G. J., Henson, G. W., Clercq, E. D., Schwartz, T. W., & Schols, D. (2001) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)23060-1 · Cited by 118
Huggins, J., Zhang, Z., & Bray, M. (1999) · The Journal of Infectious Diseases · doi:10.1086/514316 · Cited by 116
Inhibition of HIV Infection by Bicyclams, Highly Potent and Specific CXCR4 Antagonists
Clercq, E. D. (2000) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)26490-7 · Cited by 114
Margolis, D. M., Heredia, A., Gaywee, J. K., Oldach, D., Drusano, G. L., & Redfield, R. R. (1999) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00126334-199908150-00002 · Cited by 113
Pluymers, W., Neamati, N., Pannecouque, C. C., Fikkert, V., Marchand, C., Burke, T. R., Pommier, Y. G., Schols, D., Clercq, E. D., Debyser, Z., et al. (2000) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12431-5 · Cited by 112
Dragovich, P. S., Webber, S. E., Babine, R. E., Fuhrman, S. A., Patick, A. K., Matthews, D. A., Reich, S., Marakovits, J. T., Prins, T. J., Zhou, R., et al. (1998) · Journal of Medicinal Chemistry · doi:10.1021/jm9800696 · Cited by 112
Clercq, E. D., Cools, M., Balzarini, J. M., Márquez, V. E., Borcherding, D. R., BORCHARDT, R. T., Drach, J. C., Kitaoka, S., & Konno, T. (1989) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.33.8.1291 · Cited by 112
Barnett, J. M., Cadman, A., Gor, D., Dempsey, M. H., Walters, M. S., Candlin, A., Tisdale, M., Morley, P. J., Owens, I. J., Fenton, R. J., et al. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.1.78-87.2000 · Cited by 104
A General Model for the Surface Glycoproteins of HIV and Other Retroviruses
Gallaher, W. R., Ball, J. M., Garry, R. F., MARTIN-AMEDEE, A. M., & Montelaro, R. C. (1995) · AIDS Research and Human Retroviruses · doi:10.1089/aid.1995.11.191 · Cited by 104
In Vivo Influenza Virus-Inhibitory Effects of the Cyclopentane Neuraminidase Inhibitor RWJ-270201
Sidwell, R. W., Smee, D. F., Huffman, J. H., Barnard, D. L., Bailey, K. W., Morrey, J. D., & Babu, Y. S. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.3.749-757.2001 · Cited by 98
Dragovich, P. S., Webber, S. E., Babine, R. E., Fuhrman, S. A., Patick, A. K., Matthews, D. A., Lee, C. A., Reich, S., Prins, T. J., Marakovits, J. T., et al. (1998) · Journal of Medicinal Chemistry · doi:10.1021/jm980068d · Cited by 92
Retroviral integrase inhibitors year 2000: update and perspectives
Pommier, Y. G., Marchand, C., & Neamati, N. (2000) · Antiviral Research · doi:10.1016/s0166-3542(00)00112-1 · Cited by 90
Daelemans, D., Schols, D., Witvrouw, M., Pannecouque, C. C., Hatse, S., Dooren, S. V., Hamy, F., Klimkait, T., Clercq, E. D., & Vandamme, A. (2000) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)26449-x · Cited by 84
Dragovich, P. S., Prins, T. J., Zhou, R., et al. (2002) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(02)00008-2 · Cited by 78
HIV-1 Integrase as a Target for Antiviral Drugs
Pommier, Y. G., Pilon, A. A., Bajaj, K., Mazumder, A., & Neamati, N. (1997) · Antiviral chemistry & chemotherapy · doi:10.1177/095632029700800601 · Cited by 74
Dragovich, P. S., Prins, T. J., Zhou, R., et al. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm980537b · Cited by 68
Balzarini, J. M., Aquaro, S., Knispel, T., Rampazzo, C., Bianchi, V., Perno, C. F., Clercq, E. D., & Meier, C. (2000) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12464-9 · Cited by 59
Siddiqui, A. Q., McGuigan, C., Ballatore, C., Zuccotto, F., Gilbert, I. H., Clercq, E. D., & Balzarini, J. M. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm9807104 · Cited by 57
Synthesis and antiviral activity of monobactams inhibiting the human cytomegalovirus protease
Ogilvie, W. W., Yoakim, C., Dô, F., et al. (1999) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(99)00094-2 · Cited by 51
Turpin, J. A., Buckheit, R. W., Derse, D., Hollingshead, M. G., Williamson, K., Palamone, C., Osterling, M. C., Hill, S. A., Graham, L. M., Schaeffer, C. A., et al. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.3.487 · Cited by 51
Pelemans, H., Esnouf, R. M., Clercq, E. D., & Balzarini, J. M. (2000) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)26505-6 · Cited by 51
Borthwick, A. D., Angier, S. J., Crame, A. J., et al. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm000078q · Cited by 46
Margolis, D. M., Heredia, A., Gaywee, J. K., Oldach, D., Drusano, G. L., & Redfield, R. (1999) · Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology · doi:10.1097/00042560-199908150-00002 · Cited by 46
The identification of α-ketoamides as potent inhibitors of hepatitis c virus nS3-4a proteinase
Bennett, J. M., Campbell, A. D., Campbell, A., Carr, M. G., Dunsdon, R. M., Greening, J. R., Hurst, D., Jennings, N. S., Jones, P. S., Jordan, S. R., et al. (2001) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(00)00654-5 · Cited by 43
Human Immunodeficiency Virus Gene Regulation as a Target for Antiviral Chemotherapy
Daelemans, D., Vandamme, A., & Clercq, E. D. (1999) · Antiviral chemistry & chemotherapy · doi:10.1177/095632029901000101 · Cited by 36
Enzymatic properties of hepatitis C virus NS3-associated helicase
Paolini, C., Francesco, R. D., & Gallinari, P. (2000) · Microbiology · doi:10.1099/0022-1317-81-5-1335 · Cited by 33
Cited by
How were new medicines discovered?
Swinney, D. C., & Anthony, J. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3480 · Cited by 1,812
Approved Antiviral Drugs over the Past 50 Years
De Clercq, E., & Li, G. (2016) · Clinical Microbiology Reviews · doi:10.1128/cmr.00102-15 · Cited by 1,430
Self-citationA Review on Antibacterial, Antiviral, and Antifungal Activity of Curcumin
Zorofchian Moghadamtousi, S., Abdul Kadir, H., Hassandarvish, P., Tajik, H., Abubakar, S., & Zandi, K. (2014) · BioMed Research International · doi:10.1155/2014/186864 · Cited by 1,251
Eastman, R. T., Roth, J. S., Brimacombe, K. R., Simeonov, A., Shen, M., Patnaik, S., & Hall, M. D. (2020) · ACS Central Science · doi:10.1021/acscentsci.0c00489 · Cited by 953
Antiviral drugs in current clinical use
De Clercq, E. (2004) · Journal of Clinical Virology · doi:10.1016/j.jcv.2004.02.009 · Cited by 947
Self-citation
Metadata
- Authors
- De Clercq, E.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2002-01
- Volume
- 1
- Issue
- 1
- Pages
- 13-25
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2017436619
- Cited by
- 652
- References
- 65
- FWCI
- 5.37
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.